Logo for the University of Illinois at Chicago
    • Login
    View Item 
    •   INDIGO Home
    • Dissertations and Theses at UIC
    • UIC Dissertations and Theses
    • View Item
    •   INDIGO Home
    • Dissertations and Theses at UIC
    • UIC Dissertations and Theses
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    High Throughput Discovery, Metabolism and Disposition of Chemopreventive Agents using Mass Spectrometry

    Thumbnail
    View/Open
    Chen_Lian.pdf (1.381Mb)
    Date
    2013-06-28
    Author
    Chen, Lian
    Metadata
    Show full item record
    Abstract
    Cancer chemoprevention uses natural, synthetic, or biologic chemical agents to reverse, suppress or prevent the initial, promotion and/or progression of cancer. The successful development of new chemotherapeutic agents that target specific signal transduction pathways and achieve dramatic improvements in efficacy without significant cytotoxicity will be important for the future of cancer chemoprevention. As a nuclear receptor, the retinoid X receptor (RXR) is involved in the regulation of multiple anti-cancer pathways including several of those involved in cell proliferation, differentiation and apoptosis. Ligand-mediated activation of the RXR is a strategy for cancer chemoprevention and therapy. Ultrafiltration mass spectrometric screening greatly facilitated the screening for ligands of RXRα. AM6-36 was identified as structurally unique rexinoid and a leading chemopreventive agent based in high throughput screening. The preliminary metabolism studies of AM6-36 suggest that AM6-36 will not form reactive, potentially toxic metabolites. AM6-36 showed moderate serum protein binding, moderate metabolic stability, and low first-pass liver metabolism is predicted. These properties are favorable for further investigation and development of AM6-36 as a potential chemoprevention and cancer therapeutic agent. Two Topoisomerase I inhibotors, indimitecan (LMP776) and indotecan (LMP400) were promoted into Phase I clinical trials at the National Cancer Institute. These compounds appear to be stable and are powerful, cytotoxic Top1 poisons that induce long-lasting DNA breaks and overcome the drug resistance issues associated with the camptothecins. The metabolism of LMP400 and LMP776 is currently under investigation, which has led to the synthesis of potential metabolites to be used as synthetic standards for metabolism studies. O-dealkylation and demethylenation are two major metabolic pathways of LMP400 and LMP776 observed to occur in human liver microsomes. In conclusion, LC-MS has provided superior sensitivity and selectivity needed for analytical challenges, making it well suited for drug metabolism as well as other ADME related evaluation of lead compounds from screening.
    Subject
    Mass Spectrometry
    Liquid chromatography - mass spectrometry (LC-MS)
    Cancer chemoprevention
    Metabolism
    High Throughput Discovery
    Type
    thesis
    text
    Date available in INDIGO
    2013-06-28T17:26:27Z
    URI
    http://hdl.handle.net/10027/9905
    Collections
    • UIC Dissertations and Theses

    DSpace software copyright © 2002-2015  DuraSpace
    Contact Us | Send Feedback | Privacy Statement
    Theme by 
    Atmire NV

    Browse

    All of INDIGOCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    Statistics

    View Usage Statistics

    DSpace software copyright © 2002-2015  DuraSpace
    Contact Us | Send Feedback | Privacy Statement
    Theme by 
    Atmire NV